In this empiric evaluation of tau-clinical mismatch, we found that individuals classified as cognitively vulnerable appeared to exhibit higher levels of copathology and more rapid clinical decline even after accounting for differences in the level of AD pathology. Here, MAPT is linked to Alzheimer disease.